Norgestimate; Ethinyl Estradiol; Folic acid

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Interactions

Conditions

Drug Interactions, Healthy, Pharmacokinetics

Trial Timeline

May 1, 2005 โ†’ Jul 1, 2005

About Norgestimate; Ethinyl Estradiol; Folic acid

Norgestimate; Ethinyl Estradiol; Folic acid is a phase 1 stage product being developed by Johnson & Johnson for Drug Interactions. The current trial status is completed. This product is registered under clinical trial identifier NCT00709982. Target conditions include Drug Interactions, Healthy, Pharmacokinetics.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT00709982Phase 1Completed
NCT00709332Phase 1Completed